CENCERBO Trademark

Trademark Overview


On Wednesday, August 6, 2003, a trademark application was filed for CENCERBO with the United States Patent and Trademark Office. The USPTO has given the CENCERBO trademark a serial number of 78283831. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 20, 2011. This trademark is owned by Glaxo Group Limited. The CENCERBO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations; Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

General Information


Serial Number78283831
Word MarkCENCERBO
Filing DateWednesday, August 6, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 20, 2011
Registration Number2895612
Registration DateTuesday, October 19, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 27, 2004

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations; Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 20, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Trademark Events


Event DateEvent Description
Friday, May 20, 2011CANCELLED SEC. 8 (6-YR)
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 22, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 22, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 19, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, July 27, 2004PUBLISHED FOR OPPOSITION
Wednesday, July 7, 2004NOTICE OF PUBLICATION
Tuesday, April 27, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 4, 2004Sec. 1(B) CLAIM DELETED
Wednesday, February 4, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 4, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 26, 2004LETTER OF SUSPENSION E-MAILED
Monday, January 26, 2004ASSIGNED TO EXAMINER